Vanberra Signal
Free trial

Health Heritage

Curated by Signal

Clinical decision support for personalized risk assessment for major inheritable cancers.

Life Sciences Technologyhealthheritage.org

Overview

Health Heritage is an online genomic medicine decision support application that aggregates and analyzes data from medical records, genetic tests and family history to assess disease risk. It helps healthcare providers decide on the most appropriate testing and therapy for high-risk patients, avoid unnecessary testing for those without much risk and produces the medical justification insurers seek before paying for genetic screening.

Key facts

Founded
2014
Headquarters
Chicago, United States
Stage
Sign up to view
Industry
Life Sciences Technology

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

  • Expansion Therapeutics

    Provider of a software system for the development of drugs

    Life Sciences TechnologySan Diego, United States

  • Lantheus

    Developer of diagnostic imaging agents and targeted therapeutics

    Life Sciences TechnologyBillerica, United States

  • MasSpec Pen Technology

    Provider of device for detecting cancerous tissue in real time

    Life Sciences TechnologyScottsdale, United States

About Health Heritage

What does Health Heritage do?

Health Heritage is an online genomic medicine decision support application that aggregates and analyzes data from medical records, genetic tests and family history to assess disease risk.

Where is Health Heritage headquartered?

Health Heritage is headquartered in Chicago, United States.

When was Health Heritage founded?

Health Heritage was founded in 2014.

Which sector is Health Heritage in?

Health Heritage operates in Life Sciences Technology.

Who are Health Heritage's competitors?

Companies similar to Health Heritage include Expansion Therapeutics, Lantheus, and MasSpec Pen Technology.